tiprankstipranks
Trending News
More News >
Aardvark Therapeutics, Inc. (AARD)
:AARD
US Market
Advertisement

Aardvark Therapeutics, Inc. (AARD) Technical Analysis

Compare
67 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
0Bearish
Aardvark Therapeutics, Inc.’s (AARD) Moving Averages Convergence Divergence (MACD) indicator is 1.73, suggesting Aardvark Therapeutics, Inc. is a Sell.
Aardvark Therapeutics, Inc.’s (AARD) 20-Day exponential moving average is 13.20, while Aardvark Therapeutics, Inc.’s (AARD) share price is $17.41, making it a Buy.
Aardvark Therapeutics, Inc.’s (AARD) 50-Day exponential moving average is 11.86, while Aardvark Therapeutics, Inc.’s (AARD) share price is $17.41, making it a Buy.

Aardvark Therapeutics, Inc. (AARD) Pivot Points

Oct 08, 2025, 01:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.09
14.95
16.00
16.86
17.91
18.77
19.83
Fibonacci
14.95
15.68
16.13
16.86
17.59
18.04
18.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aardvark Therapeutics, Inc. (AARD) Moving Averages

Oct 08, 2025, 01:26 PM
Period
Simple
Exponential
MA5
16.12Buy
16.16Buy
MA10
14.57Buy
14.83Buy
MA20
12.30Buy
13.20Buy
MA50
11.13Buy
11.86Buy
MA100
11.61Buy
11.33Buy
MA200
Aardvark Therapeutics, Inc.’s (AARD) 10-Day exponential moving average is 14.83, while Aardvark Therapeutics, Inc.’s (AARD) share price is $17.41, making it a Buy.
Aardvark Therapeutics, Inc.’s (AARD) 100-Day exponential moving average is 11.33, while Aardvark Therapeutics, Inc.’s (AARD) share price is $17.41, making it a Buy.
Aardvark Therapeutics, Inc.’s (AARD) stock price is $17.41 and Aardvark Therapeutics, Inc.’s (AARD) 50-day simple moving average is 11.13, creating a Buy signal.
Aardvark Therapeutics, Inc.’s (AARD) stock price is $17.41 and Aardvark Therapeutics, Inc.’s (AARD) 100-day simple moving average is 11.61, creating a Buy signal.

Aardvark Therapeutics, Inc. (AARD) Technical Indicators

Oct 08, 2025, 01:26 PM
Name
Value
Implied Action
RSI (14)
82.49
Sell
STOCH (9,6)
92.14
Sell
STOCHRSI (14)
93.54
Sell
MACD (12,26)
1.73
Sell
ADX (14)
44.91
Neutral
Williams %R
-6.59
Sell
CCI (14)
149.78
Sell
ATR (14)
1.14
-
Ultimate Oscillator
67.49
Neutral
ROC
58.71
Buy
Aardvark Therapeutics, Inc.’s (AARD) Relative Strength Index (RSI) is 82.49, creating a Sell signal.
Aardvark Therapeutics, Inc.’s (AARD) Trend Strength Indicator (ADX) is 44.91, creating a Neutral signal.
Aardvark Therapeutics, Inc.’s (AARD) Commodity Channel Index (CCI) is 149.78, creating a Sell signal.
Aardvark Therapeutics, Inc.’s (AARD) Price Rate of Change (ROC) is 58.71, creating a Buy signal.

FAQ

Is AARD a Buy, Hold, or Sell?
Based on AARD’s technical indicators, AARD is a Buy.
    What is AARD’s RSI (14)?
    AARD’s RSI (14) is 82.49, which suggests AARD is a Sell.
      What is AARD’s MACD?
      AARD’s MACD is 1.73, which suggests AARD is a Sell.
        What is AARD’s 5-day moving average?
        AARD’s 5-day moving average is 16.12, which suggests AARD is a Buy.
          What is AARD’s 20-day moving average?
          AARD 20-day moving average is 12.30, which suggests AARD is a Buy.
            What is AARD’s 50-day moving average?
            AARD’s 50-day moving average is 11.13, which suggests AARD is a Buy.
              What is AARD’s 200-day moving average?
              Currently, no data Available
              What is AARD’s Williams % R (14)?
              AARD’s Williams % R (14) is -6.59, which suggests AARD is a Sell.
                What is AARD’s CCI (14)?
                AARD’s CCI (14) is 149.78, which suggests AARD is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis